1887

Abstract

Epstein–Barr virus (EBV) is a human herpesvirus associated with a number of malignancies. EBV establishes a latent infection in human B cells , and infected lymphoblastoid cells proliferate indefinitely as a result of virus activation of cellular signalling pathways. Latently infected cells express a viral oncoprotein called the latent membrane protein-1 (LMP-1). LMP-1 signals both proliferative and survival signals to the infected B cell. The switch from latency to lytic replication is associated with upregulation of an N-terminally truncated LMP-1, called lytic LMP-1 (lyLMP-1). To understand better the relationship between LMP-1 protein function and the virus life cycle, LMP-1 and lyLMP-1 were precisely localized in infected B cells. Immunoelectron microscopy of latently infected cells revealed LMP-1 localized in discrete patches in the plasma membrane. Unexpectedly, immunogold-labelled LMP-1 was found in vesicles budding from the plasma membrane into the extracellular space and in small membrane vesicles accumulating in conditioned medium from infected cells. LyLMP-1 immunolabelling was observed only in B95-8 cells harbouring detectable intracellular virus particles and was abundant in the nuclear membrane early, and in the plasma membrane late, following lytic cycle induction. LyLMP-1 immunoreactivity was also observed at sites of virus budding and associated with intracellular virions, suggesting that lyLMP-1 might be incorporated into cytoplasmic virions when budding through the nuclear membrane.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19156-0
2003-08-01
2019-10-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/8/vir841997.html?itemId=/content/journal/jgv/10.1099/vir.0.19156-0&mimeType=html&fmt=ahah

References

  1. Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B. & Bornkamm, G. W. ( 2002; ). Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc Natl Acad Sci U S A 99, 437–442.[CrossRef]
    [Google Scholar]
  2. Baichwal, V. R. & Sugden, B. ( 1987; ). Posttranslational processing of an Epstein–Barr virus-encoded membrane protein expressed in cells transformed by Epstein–Barr virus. J Virol 61, 866–875.
    [Google Scholar]
  3. Baichwal, V. R. & Sugden, B. ( 1989; ). The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein–Barr virus are required for transformation. Oncogene 4, 67–74.
    [Google Scholar]
  4. Cannon, M. J., Pisa, P., Fox, R. I. & Cooper, N. R. ( 1990; ). Epstein–Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 85, 1333–1337.[CrossRef]
    [Google Scholar]
  5. Coffin, W. F., III, Erickson, K. D., Hoedt-Miller, M. & Martin, J. M. ( 2001; ). The cytoplasmic amino-terminus of the latent membrane protein-1 of Epstein–Barr virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain. Oncogene 20, 5313–5330.[CrossRef]
    [Google Scholar]
  6. Cohen, J. I. ( 1991; ). Epstein–Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70, 137–160.[CrossRef]
    [Google Scholar]
  7. Dukers, D. F., Meij, P., Vervoort, M. B. H. J., Vos, W., Scheper, R. J., Meijer, C. J. L. M., Bloemena, E. & Middeldorp, J. M. ( 2000; ). Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165, 663–670.[CrossRef]
    [Google Scholar]
  8. Eliopoulos, A. G. & Rickinson, A. B. ( 1998; ). Epstein–Barr virus: LMP1 masquerades as an active receptor. Curr Biol 8, R196–R198.[CrossRef]
    [Google Scholar]
  9. Erickson, K. D. & Martin, J. M. ( 1997; ). Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion. Virology 234, 1–13.[CrossRef]
    [Google Scholar]
  10. Erickson, K. D. & Martin, J. M. ( 2000; ). The late lytic LMP-1 protein of Epstein–Barr virus can negatively regulate LMP-1 signaling. J Virol 74, 1057–1060.[CrossRef]
    [Google Scholar]
  11. Escola, J., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O. & Geuze, H. J. ( 1998; ). Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273, 20121–20127.[CrossRef]
    [Google Scholar]
  12. Fennewald, S., van Santen, V. & Kieff, E. ( 1984; ). Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 51, 411–419.
    [Google Scholar]
  13. Floettmann, J. E., Ward, K., Rickinson, A. B. & Rowe, M. ( 1996; ). Cytostatic effect of Epstein–Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223, 29–40.[CrossRef]
    [Google Scholar]
  14. Garnier, J. L., Berger, F., Betuel, H. & 7 other authors ( 1989; ). Epstein–Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant 4, 818–823.
    [Google Scholar]
  15. Giddings, T. H., Jr, O'Toole, E. T., Morphew, M., Mastronarde, D. N., McIntosh, J. R. & Winey, M. ( 2001; ). Using rapid freeze and freeze-substitution for the preparation of yeast cells for electron microscopy and three-dimensional analysis. Methods Cell Biol 67, 27–42.
    [Google Scholar]
  16. Gong, M. & Kieff, E. ( 1990; ). Intracellular trafficking of two major Epstein–Barr virus glycoproteins, gp350/220 and gp110. J Virol 64, 1507–1516.
    [Google Scholar]
  17. Hammerschmidt, W., Sugden, B. & Baichwal, V. R. ( 1989; ). The transforming domain alone of the latent membrane protein of Epstein–Barr virus is toxic to cells when expressed at high levels. J Virol 63, 2469–2475.
    [Google Scholar]
  18. Henle, G., Henle, W. & Diehl, V. ( 1968; ). Relation of Burkitt's tumor associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A 59, 94–101.[CrossRef]
    [Google Scholar]
  19. Higuchi, M., Izumi, K. M. & Kieff, E. ( 2001; ). Epstein–Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc Natl Acad Sci U S A 98, 4675–4680.[CrossRef]
    [Google Scholar]
  20. Ho, M., Jaffe, R., Miller, G. & 7 other authors ( 1988; ). The frequency of Epstein–Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45, 719–727.[CrossRef]
    [Google Scholar]
  21. Hudson, G. S., Farrell, P. J. & Barrell, B. G. ( 1985; ). Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein–Barr virus B95-8. J Virol 53, 528–535.
    [Google Scholar]
  22. Huen, D. S., Henderson, S. A., Croom-Carter, D. & Rowe, M. ( 1995; ). The Epstein–Barr virus latent membrane protein-1 (LMP1) mediates activation of NFκB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10, 549–560.
    [Google Scholar]
  23. Izumi, K. M., Kaye, K. M. & Kieff, E. D. ( 1997; ). The Epstein–Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci U S A 94, 1447–1452.[CrossRef]
    [Google Scholar]
  24. Kavathas, P., Bach, F. H. & DeMars, R. ( 1980; ). Gamma ray-induced loss of expression of HLA and glyoxylase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A 77, 4251–4255.[CrossRef]
    [Google Scholar]
  25. Kaye, K. M., Izumi, K. M. & Kieff, E. ( 1993; ). Epstein–Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90, 9150–9154.[CrossRef]
    [Google Scholar]
  26. Kaykas, A. & Sugden, B. ( 2000; ). The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 19, 1400–1410.[CrossRef]
    [Google Scholar]
  27. Kaykas, A., Worringer, K. & Sugden, B. ( 2001; ). CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J 20, 2641–2654.[CrossRef]
    [Google Scholar]
  28. Kilger, E., Kieser, A., Baumann, M. & Hammerschmidt, W. ( 1998; ). Epstein–Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17, 1700–1709.[CrossRef]
    [Google Scholar]
  29. Liebowitz, D., Wang, D. & Kieff, E. ( 1986; ). Orientation and patching of the latent infection membrane protein encoded by Epstein–Barr virus. J Virol 58, 233–237.
    [Google Scholar]
  30. Mann, K. P., Staunton, D. & Thorley-Lawson, D. ( 1985; ). Epstein–Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol 55, 710–720.
    [Google Scholar]
  31. Miller, G. ( 1985; ). Epstein–Barr virus. In Virology, 1 edn, pp. 563–589. Edited by B. N. Fields. New York: Raven Press.
  32. Miller, G. ( 1989; ). The switch between EBV latency and replication. Yale J Biol Med 62, 205–213.
    [Google Scholar]
  33. Miller, G. & Lipman, M. ( 1973; ). Release of infectious Epstein–Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 70, 190–194.[CrossRef]
    [Google Scholar]
  34. Miller, G., Shope, T., Lisco, H., Stitt, D. & Lipman, M. ( 1972; ). Epstein–Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A 69, 383–387.[CrossRef]
    [Google Scholar]
  35. Mitchell, T. & Sugden, B. ( 1995; ). Stimulation of NFκB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein–Barr virus. J Virol 69, 2968–2976.
    [Google Scholar]
  36. Niederman, J. C., McCollum, R. W., Henle, G. & Henle, W. ( 1968; ). Infectious mononucleosis. JAMA 203, 139–143.
    [Google Scholar]
  37. Prince, S., Keating, S., Fielding, C., Brennan, P., Floettmann, E. & Rowe, M. ( 2002; ). Latent membrane protein 1 inhibits Epstein–Barr virus lytic cycle induction and progress by different mechanisms. J Virol 77, 5000–5007.
    [Google Scholar]
  38. Raposo, G., Nijman, H. W., Stoorvogel, W., Leijendekker, R., Harding, C. V., Melief, C. J. M. & Geuze, H. J. ( 1996; ). B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183, 1161–1172.[CrossRef]
    [Google Scholar]
  39. Steven, A. & Spear, P. G. ( 1997; ). Herpesvirus capsid assembly and envelopment. In Structural Biology of Viruses, pp. 312–351. Edited by W. Chiu, W. Burnett & R. L. Garcea. New York: Oxford University Press.
  40. Sugden, B. ( 1982; ). Epstein–Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Rev Infect Dis 4, 1048–1061.[CrossRef]
    [Google Scholar]
  41. Sugden, B. ( 1989; ). An intricate route to immortality. Cell 57, 5–7.[CrossRef]
    [Google Scholar]
  42. Sugden, B. & Mark, W. ( 1977; ). Clonal transformation of adult human leukocytes by Epstein–Barr virus. J Virol 23, 503–508.
    [Google Scholar]
  43. Torrisi, M. R., Cirone, M., Pavan, A., Zompetta, C., Barile, G., Frati, L. & Faggioni, A. ( 1989; ). Localization of Epstein–Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J Virol 63, 828–832.
    [Google Scholar]
  44. Wang, D., Liebowitz, D. & Kieff, E. ( 1988a; ). The truncated form of the Epstein–Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J Virol 62, 2337–2346.
    [Google Scholar]
  45. Wang, D., Liebowitz, D., Wang, F., Gregory, C., Rickinson, A., Larson, R., Springer, T. & Kieff, E. ( 1988b; ). Epstein–Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 62, 4173–4184.
    [Google Scholar]
  46. Wild, P., Schraner, E. M., Cantieni, D., Loepfe, E., Walther, P., Muller, M. & Engels, M. ( 2002; ). The significance of the Golgi complex in envelopment of bovine herpesvirus 1 (BHV-1) as revealed by cryobased electron microscopy. Micron 33, 327–337.[CrossRef]
    [Google Scholar]
  47. Zimber-Strobl, U., Kempkes, B., Marschall, G., Zeidler, R., Van Kooten, C., Banchereau, J., Bornkamm, G. W. & Hammerschmidt, W. ( 1996; ). Epstein–Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J 15, 7070–7078.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19156-0
Loading
/content/journal/jgv/10.1099/vir.0.19156-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error